Trust page

Built for teams that need regulatory judgment, not only links

MedTech Atlas combines structured public references with practical project experience. The site helps companies prepare informed discussions; specific filing decisions still require product, company, and target-country context.

Why companies use us as a reference layer

Nearly 20 years of compliance background

The team background spans regulatory affairs, quality systems, registration planning, and compliance execution for medical device projects.

Global certification experience

Experience covers certification and registration preparation across multiple countries and regulatory systems, including reference-approval strategy.

Localization delivery experience

Project work includes local holder models, distributor and importer role design, document localization, labeling, and post-market responsibility planning.

How we work

Start from product type, risk class, intended use, and existing evidence instead of generic country claims.

Compare the target-country pathway with reusable FDA, CE, MDSAP, NMPA, ISO, IEC, clinical, and QMS evidence.

Separate reference value from formal exemption: a certificate may help credibility without replacing local filing.

Turn the assessment into an execution map: holder, dossier, labeling, language, timeline, partner role, and risk control.

Official-source discipline

Country pages are maintained as decision-support material and should be verified against current regulator guidance before filing.

Country-by-country caution

Even when two countries accept similar evidence, local holder, labeling, fees, system registration, and post-market duties can differ.

Implementation orientation

The goal is not only to know the rule, but to understand what must happen locally for the product to be registered and kept compliant.

Discuss a project

Reference first, project review next

This website is a planning reference for enterprises. For deeper communication, leave company information, product details, current approvals, and target countries. We will contact you and scope the next review.

Discuss a project